MedAll’s advanced analytics were used to uncover deep insights in oncology care.
The results of the sentiment analysis initiative were compelling:
4.3k – HCPs Surveyed 10 days – Time to Results 50+ – Countries
At MedAll, we leverage our cutting-edge sentiment analysis technology to harness the collective insights from hundreds of thousands of healthcare professionals (HCPs). Our unique ability to quickly and accurately gather targeted insights transforms the landscape of medical education and practice management.
Our goal was to utilize sentiment analysis to uncover the nuanced perceptions and needs of HCPs regarding first-line immunotherapy treatments for metastatic melanoma. This targeted approach allows us to deliver highly relevant content and interventions, addressing gaps in knowledge and practice effectively.
Utilizing advanced engagement technology, our platform processed sentiments from diverse HCP interactions across multiple touch points. This capability enabled MedAll to:Measure the impact of ongoing educational programs.
Tailor content dynamically based on real-time feedback.
Identify critical HCP needs and misconceptions
Measure the impact of planned interventions on sentiment and performance
Tailor content dynamically based on real-time analysis
The sentiment analysis revealed important gaps in key areas:
Identifying practice gaps among healthcare professionals in the utilization of biomarkers
Revealing inconsistencies in adoption of new medical research
Highlighting a need for comprehensive educational programs
Opportunity to improve use of guidelines, as well as evaluation of treatment protocols
Partner with us to discover how MedAll’s sentiment analysis can provide unparalleled insights into HCP needs, patient care trends, and much more. Join us in shaping the future of healthcare with data-driven decision-making.
Please complete the form below to reach out to MedAll.
* indicates mandatory field